Abeona Therapeutics Inc.

NasdaqCM:ABEO 주식 보고서

시가총액: US$255.1m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Abeona Therapeutics 미래 성장

Future 기준 확인 2/6

Abeona Therapeutics은 연간 수입과 매출이 각각 58.2%와 59.8% 증가할 것으로 예상되고 EPS는 연간 64.2%만큼 증가할 것으로 예상됩니다.

주요 정보

53.4%

수익 성장률

56.3%

EPS 성장률

Biotechs 수익 성장28.5%
매출 성장률62.7%
향후 자기자본 수익률n/a
애널리스트 커버리지

Good

마지막 업데이트14 Aug 2024

최근 미래 성장 업데이트

Recent updates

Is Abeona Therapeutics (NASDAQ:ABEO) Using Too Much Debt?

Sep 23
Is Abeona Therapeutics (NASDAQ:ABEO) Using Too Much Debt?

We're Not Very Worried About Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Rate

May 01
We're Not Very Worried About Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Rate

We're Not Very Worried About Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Rate

Jan 04
We're Not Very Worried About Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Rate

Here's Why We're Watching Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Situation

Aug 16
Here's Why We're Watching Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Situation

Can Abeona Therapeutics (NASDAQ:ABEO) Afford To Invest In Growth?

Mar 31
Can Abeona Therapeutics (NASDAQ:ABEO) Afford To Invest In Growth?

Abeona: Pivotal Data Readout EB-101 Before Year End Could Boost Shareholder Value

Oct 19

Abeona Therapeutics stock continues recent strong run, shares rise ~10%

Oct 04

Abeona Therapeutics GAAP EPS of -$2.08, revenue of $1M

Aug 11

Abeona therapeutics regains compliance with Nasdaq minimum bid price requirement

Jul 20

Abeona crashes 21% as reverse stock split takes effect

Jul 05

Here's Why Abeona Therapeutics (NASDAQ:ABEO) Must Use Its Cash Wisely

Mar 02
Here's Why Abeona Therapeutics (NASDAQ:ABEO) Must Use Its Cash Wisely

Here's Why Abeona Therapeutics (NASDAQ:ABEO) Can Manage Its Debt Despite Losing Money

Aug 17
Here's Why Abeona Therapeutics (NASDAQ:ABEO) Can Manage Its Debt Despite Losing Money

Abeona Therapeutics shares rise after letter to stockholders

May 26

Despite Lacking Profits Abeona Therapeutics (NASDAQ:ABEO) Seems To Be On Top Of Its Debt

Apr 28
Despite Lacking Profits Abeona Therapeutics (NASDAQ:ABEO) Seems To Be On Top Of Its Debt

Independent Director Paul Mann Just Sold A Bunch Of Shares In Abeona Therapeutics Inc. (NASDAQ:ABEO)

Feb 21
Independent Director Paul Mann Just Sold A Bunch Of Shares In Abeona Therapeutics Inc. (NASDAQ:ABEO)

How Much Did Abeona Therapeutics'(NASDAQ:ABEO) Shareholders Earn From Share Price Movements Over The Last Three Years?

Jan 19
How Much Did Abeona Therapeutics'(NASDAQ:ABEO) Shareholders Earn From Share Price Movements Over The Last Three Years?

What Kind Of Investors Own Most Of Abeona Therapeutics Inc. (NASDAQ:ABEO)?

Dec 15
What Kind Of Investors Own Most Of Abeona Therapeutics Inc. (NASDAQ:ABEO)?

수익 및 매출 성장 예측

NasdaqCM:ABEO - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
12/31/202671-40-31-596
12/31/202514-71-52-666
12/31/20240-62-60-646
6/30/2024N/A-53-44-42N/A
3/31/20244-77-41-40N/A
12/31/20234-54-37-37N/A
9/30/20234-45-42-42N/A
6/30/20234-39-43-43N/A
3/31/20231-31-42-42N/A
12/31/20221-43-44-43N/A
9/30/20224-83-63-60N/A
6/30/20224-84-67-63N/A
3/31/20223-91-70-66N/A
12/31/20213-85-70-66N/A
9/30/20213-54-38-37N/A
6/30/202110-54-38-37N/A
3/31/202110-52-37-35N/A
12/31/202010-84-36-35N/A
9/30/20207-85-49-48N/A
6/30/2020N/A-95-57-55N/A
3/31/2020N/A-106-67-61N/A
12/31/2019N/A-76-69-63N/A
9/30/20190-77-83-66N/A
6/30/20192-76-74-56N/A
3/31/20192-65-67-50N/A
12/31/20183-57-59-39N/A
9/30/20183-48-36-27N/A
6/30/20181-37-33-25N/A
3/31/20181-33N/A-21N/A
12/31/20171-27N/A-23N/A
9/30/20171-26N/A-21N/A
6/30/20171-23N/A-18N/A
3/31/20171-22N/A-16N/A
12/31/20161-22N/A-13N/A
9/30/20161-17N/A-12N/A
6/30/20161-21N/A-11N/A
3/31/20161-18N/A-10N/A
12/31/20151-15N/A-10N/A
9/30/20151-25N/A-9N/A
6/30/20151-21N/A-6N/A
3/31/20151-30N/A-5N/A
12/31/20141-30N/A-2N/A
9/30/20141-19N/A-1N/A
6/30/20141-17N/A-2N/A
3/31/20141-3N/A0N/A
12/31/201322N/A0N/A
9/30/2013322N/A-1N/A

애널리스트 미래 성장 예측

수입 대 저축률: ABEO 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

수익 vs 시장: ABEO 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

고성장 수익: ABEO 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

수익 대 시장: ABEO 의 수익(연간 59.8% ) US 시장( 8.7% 보다 빠르게 성장할 것으로 예상됩니다. 8.7% 연간).

고성장 수익: ABEO 의 수익(연간 59.8% )은 연간 20% 보다 빠르게 증가할 것으로 예상됩니다.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: ABEO 의 자기자본수익률이 3년 내에 높을 것으로 예상되는지 판단하기에는 데이터가 부족합니다.


성장 기업 발견